Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial.
Neuhauser
H
H
Neurologische Klinik, Charité, Humboldt-Universität, Berlin, Germany. neuhauserh@rki.de
Radtke
A
A
von Brevern
M
M
Lempert
T
T
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use*; D016896:Treatment Outcome; D014363:Tryptamines; D014717:Vertigo / Q000150:complications / Q000188:drug therapy*
D023303:Oxazolidinones; D014363:Tryptamines; C089750:zolmitriptan